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Abstract: The anthocyanin content of Hungarian sour cherry is remarkable based on our preliminary
investigations. Nutraceutical and pharmaceutical effects of anthocyanins have been extensively
studied. The objective of this work was to investigate the the effect of purified sour cherry extract using
human umbilical cord vein endothelial cells (HUVECs) as the inflammatory model. HUVECs were
isolated by enzymatic digestion and characterized by flow cytometry. The optimal concentration
range of sour cherry extract was selected based on MTT, apoptosis, and necrosis assays. Cells were
divided into three groups, incubating with M199 medium as control, or with lipopolysaccharide
(LPS) or with LPS plus anthocyanin extract (ACE). The effect of sour cherry extract on oxidative stress,
pro-inflammatory factors, and arachidonic pathway was investigated. An amount of 50 µg/mL ACE
(ACE50) was able to increase the level of glutathione and decrease the ROS, thereby improving the
unbalanced redox status in inflammation. ACE50 lowered pro-inflammatory cytokine levels including
Interleukin-6 (IL-6), regulated on activation, normal T cell expressed and secreted (RANTES),
granulocyte-macrophage colony-stimulating factor (GM-CSF), and tumor necrosis factor alpha
(TNF-α). ACE50 affected the arachidonic acid pathway by reducing the LPS-induced enzyme
expression (cyclooxygenase-1, cyclooxygenase-2, and prostacyclin synthase). The extract under
investigation seems to have a pleiotropic effect including anti-oxidative, anti-inflammatory, hemostatic,
and vasoactive effects. Our results indicate that purified sour cherry extract could reduce the
LPS-induced inflammatory response, thereby improving endothelial dysfunction.
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1. Introduction
Polyphenol compounds including flavonoids are secondary metabolic products of plants that
play a protective role against different stress effects. Anthocyanins are a subgroup of flavonoids.
Regarding chemical structure, they have a positive charge at the oxygen atom of the C-ring of the
basic flavonoid structure. Anthocyanins are commonly found in flowers and fruits, and some of these
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plants have been traditionally used as colorants and food [1]. The main sources of anthocyanins are
red berry fruits, red grapes, red wine, crops (e.g., purple maize), and different red cabbage varieties [2].
Current research trends clearly indicate that natural products are one of the most important sources of
new drugs [3]. Anthocyanins are also used in traditional medicine for the treatment of various diseases.
In recent decades, anthocyanin-related research has proved its beneficial health effects [4]. Until the
beginning of the century, anthocyanins appeared in scientific reports as chemical structures with a
high antioxidant capacity. However, today we know that apart from their antioxidant capacity they
can modulate several signal transduction pathways [5]. Anthocyanins possess anti-inflammatory [6],
antimicrobial [7], anticancer [8], antidiabetic [9], and anti-obesity effects [10], as well as the notable
prevention impact on cardiovascular diseases (CVDs) [11]. Furthermore, anthocyanins can inhibit
human salivary α-amylase and the growth of Streptococcus mutans [12].
It is well known that anthocyanins reach maximum blood concentration within 3 h. This fast
process is due to rapid absorption by the stomach [13]. Then, anthocyanins eliminate readily from
the plasma by liver degradation [14]. The biological availability is <2% [15]. The anthocyanin level
in plasma seems to be high enough to perform its biological activity, especially for those specific
targets such as endothelial cells in veins, where anthocyanins significantly modulate intracellular
signal transduction pathways and gene control activities [16].
Many studies have focused on their defensive role in inflammation [17]. A randomized control
trial also showed that the level of plasma IL-1β of hypercholesterolemic patients who consumed an
anthocyanin mixture (320 mg/day) for six months was substantially lower compared to placebo [18].
An in vivo study indicated that lipopolysaccharide (LPS)-induced mice fed with 10% blueberries had
attenuated expression of protein and mRNA of tumor necrosis factor alpha (TNF-α) and interleukin-6
(IL-6) in the blood serum compared to the control [19]. An in vitro study demonstrated decreasing
IFN-α-induced (100 ng/mL) expressions of MCP-1, IL-6, and TNF-α in human monocytic THP-1 cells
due to a treatment of 10 mg/mL anthocyanin-containing bilberry extract [20]. Another in vitro study
highlighted the protective effect of purified sour cherry anthocyanin extract on cytokine-induced
inflammatory caco-2 monolayers [21].
The investigated Hungarian sour cherry varieties synthetize anthocyanins in high concentration.
They produce selective cyanidin glycosides, the main component being cyanidin-3-O-rutinoside [22].
Other research has shown a wide range of polyphenolic compounds of sour cherry extract identified
by mass spectrometer coupled to liquid chromatography (LC-MS). That study also clarified that the
main anthocyanin components of sour cherry are cyanidin-3-rutinoside, cyanidin-3-O-glucoside, and
cyanidin-3-O-glucosyl-rutinoside [23]. In our present study, the effect of sour cherry anthocyanin
extract (ACE) was investigated in an inflammatory model. Inflammation is a biological response of
body tissues to harmful stimuli, such as pathogens, damaged cells, or irritants, by a very complex
instrument in which reactive oxygen species (ROS), cytokine burst, paracrine agents, balance of
vasodilatation and vasoconstriction compounds, and balance of hemostasis play significant roles [24].
Because human umbilical cord vein endothelial cells (HUVECs) have been extensively used to study
the biology and pathobiology of various diseases including the inflammatory process [25], we applied
HUVECs as an inflammatory model. Inflammatory response was induced by LPS, an endotoxin from
the outer membrane of bacteria, which is routinely used to trigger inflammation.
2. Results
2.1. Flow Cytometric Measurements
HUVECs were characterized to positive and negative marker expression using flow cytometry
and antibodies against specific marker proteins ICAM-1 (intracellular adhesion molecule 1, CD54),
PECAM-1 (Platelet endothelial cell adhesion molecule 1, CD31), PTPRC (protein tyrosine phosphatase
receptor type C, CD45) and VCAM-1 (vascular cell adhesion molecule 1, CD106). As shown in Figure 1,
isolated HUVECs showed high CD54 and CD31 positive marker expression levels (approximately
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90% double positive cells), whereas approximately 97% of the cells did not express CD45 and CD106
markers (Figure 1), strongly suggesting the high accuracy and efficiency of cell isolation.
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Figure 1. Flow cytometric nalysis of human umbilical cord vein endothe ial cells (HUVECs).
Isolated HUVECs were checked for positive markers (b) CD54 and CD31 and negative marker
proteins (c) 45 and CD106 expres ion using specific antib dies. (a) Forward- nd side-scatter pl t
and (b) dot-plots of HUVEC positive- and (c) neg tive-m rkers are shown. Representative graph of
three independent exp riments.
2.2. Main Compounds of Purified Sour Cherry Extract
Figure 2 shows the main components of the investigated sour cherry extract.
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2.3. Seeking of Optimal ACE Concentration
2.3.1. Up to 100 µg/mL, Survival Rate of HUVECs Was Not Altered by ACE Treatment
Prior to examining the effect of ACE on HUVECs, the effect of ACE on cell viability was evaluated.
As shown in Figure 3, we found that ACE treatment at concentrations of 1, 5, 10, 50, and 100 µg/mL
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did not result in a significant change in viability of HUVECs. To confirm the promising results of the
MTT assay, we also examined the potential apoptotic and necrotic effects of ACE using fluorescent
labelling (DilC1(5) and SYTOX Green dyes) [26]. The results show that ACE did not induce apoptotic
and necrotic events in this concentration range (Figure 4). These data suggest that the concentrations
of ACE mentioned above can be used without the risk of any biologically relevant cytotoxic actions.
According to our unpublished data, at higher concentrations of ACE (≥500 µg/mL) the viability of cells
was substantially decreased and necrotic cell death was observed.
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Figure 4. Combined fluorescent DilC1(5) and SYTOX Green labelling. To observe apoptotic and 
necrotic cell death, HUVECs were treated as indicated (A) 24 h or (B) 48 h. Results are expressed in 
the percentage of the control (100% is represented by the solid lines). Data are expressed as the mean 
± SEM of four individual experiments. CCCP, carbonyl cyanide m-chlorophenyl hydrazone (positive 
control for apoptosis); LB, lysis buffer (positive control for necrosis); ACE, anthocyanin extract. 
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Figure 3. Viability of HUVECs was evaluated at (A) 24 h and (B) 48 h. Results are expressed in the
percentage of the control (100% is represented by the solid lines). Data are expressed as the mean ± SEM
of four individual experiments. ACE, anthocyanin extract.
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necrotic cell death, HUVECs were treated as indicated (A) 24 h or (B) 48 h. Re ults are expressed
i the per ntage of the control (100% is represented by the solid lines). Data are expressed a the
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(positive control for apoptosis); LB, lysi buffer (positive control for ne rosis); ACE, anthocya in extract.
2.3.2. Determination of Effective Antioxidant Co centrations
To s l ct the appr priate concentration for furth r experiments, we also examined the antioxidant
effect of ACE. We wanted to exclude the possibility that ACE has insufficient antioxidant capacity
at low concentrations indicating biological inactivity. Cells were treated with H2O2 and levels
of reactive oxygen species (ROS) were evaluated. Amounts of 50 and 100 µg/mL were the most
effective in eliminating ROS (Figure 5). Since the maximum absorption of the main components
(cyaniding-3-O-rutinoside) of the ACE in the blood is closer to 50 µg/mL, this concentration was
selected (ACE50) and applied for further experiments [27].
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significantly higher after ACE50 treatment. 
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Figure 5. Effect of ACE on the level of reactive oxygen species (ROS) in various concentrations.
* indicates the significant increase of ROS after H2O2 treatment compared to the control. # indicates the
significant changes in ROS after H2O2 and ACE treatment compared to the H2O2 treatment without
ACE. Results are expressed in the percentage of the control (100% is represented by the solid lines).
Data are expressed as the mean ± SEM of four individual experiments. H2O2, hydrogen peroxide
(positive control for oxidative stress); ACE, anthocyanin extract.
2.4. ACE50 Inhibits LPS-Induced ROS in HUVECs
ROS production plays a pivotal role in inflammation [28]. It is well known that anthocyanins have
excellent antioxidant properties. The effect of ACE50 on the level of ROS in HUVECs was evaluated
(Figure 6A). LPS induced a considerable ROS production in the HUVECs. Incubating HUVECs with
ACE50 led to a decreased amount of ROS. We also examined the level of glutathione (GSH), which is a
good indicator of the antioxidant status [29] (Figure 6B). The level of GSH was significantly higher
after ACE50 treatment.
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Figure 6. Effect of ACE50 on the level of ROS (A). * indicates the significant increase of ROS in
lipopolysaccharide (LPS)-induced inflammation compared to the control. # indicates the significant
changes in ROS in LPS-induced inflammation and ACE50 treatment compared to the level of ROS in
LPS-induced inflammation without ACE50. Effect of ACE50 on the level of GSH (B). * indicates the
significant increase of GSH after ACE50 treatment in LPS-induced inflammation compared to the control.
Results are expressed in the percentage of the control (100% is represented by the solid lines). Data are
expressed as the mean ± SEM of four individual experiments. ACE50, 50 µg/mL anthocyanin extract.
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These observations indicate that ACE50 can improve the imbalance of pro- and anti-oxidative
agents causing the alleviation of oxidative stress.
2.5. ACE50 Decreases Secretion of Pro-Inflammatory Cytokines and Chemokines
To determine the inhibitory effect of ACE50 on cytokine and chemokine secretion by HUVECs,
IL-6, TNF-α, granulocyte-macrophage colony-stimulating factor (GM-CSF) and regulated on activation,
normal T cell expressed and secreted (RANTES) levels were evaluated in supernatant after treatment
with 100 ng/mL LPS in the presence or absence of ACE50. ACE50 was able to attenuate the level of
the above-mentioned cytokines and chemokines (Figure 7). These observations confirm that sour
cherry ACE50 can reduce inflammation on LPS-stimulated HUVECs by suppressing cytokine and
chemokine release.
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 Figure 7. The level of evaluated cytokines and chemokines increased significantly compared to the
control after LPS-treatment indicated by *. # indicates the significant changes in cytokines in LPS-induced
inflammation and ACE50 treatment compared to the level of cytokines in LPS-induced inflammation
without ACE50. Results are expressed in the percentage of the control (100% is represented by the
solid lines). Data are expressed as the mean ± SEM of four individual experiments. ACE50, 50 µg/mL
anthocyanin extract. Interleukin-6 (IL-6), regulated on activation, normal T cell expressed and secreted
(RANTES), granulocyte-macrophage colony-stimulating factor (GM-CSF), and tumor necrosis factor
alpha (TNF-α).
2.6. ACE50 Decreases Level of Tissue-Type Plasminogen Activator (tPA)
tPA has a dual function. As a serine protease, tPA plays a key role in the homeostasis of hemostasis
and the extracellular matrix regulation. As a cytokine, tPA accomplishes multiple actions by binding
to its membrane receptors and triggering intracellular signaling events [30]. tPA was investigated in
the LPS-induced inflammatory model and assessed in supernatant after treatment with 100 ng/mL
LPS in the presence or absence of ACE50. ACE50 had a similar effect on the level of tPA as on the
above-mentioned cytokines. ACE50 was able to reduce the level of tPA in LPS-induced inflammation
in HUVECs (Figure 8).
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Figure 8. The level of tPA increased significantly compared to the control after LPS-treatment indicated
by *. # indicates the significant changes in tPA in LPS-induced inflammation and ACE50 treatment
compared to the level of tPA in LPS-induced inflammation without ACE50. Results are expressed
in the percentage of the control (100% is represented by the solid lines). Data are expressed as the
mean ± SEM of four individual experiments. ACE50, 50 µg/mL anthocyanin extract.
2.7. ACE50 Impact on Arachidonic Acid Pathway
Regulatory elements of inflammation are mainly protein derivatives (cytokines, chemokines).
In addition, a achidonic acid derivatives pl y an important role in the regional co trol of inflammation
due t thei very low half-lif [31,32]. We investigated eicosanoids, which h ve both a vasoactive effect
on smooth muscle cells and aggregative/anti-aggregative effects on platelets [32]. Since ACE50 can
influence inflammatory response, we inves gated the arachidonic acid pathw y as well. We examined
the level of thromboxane (TxA2) and prostacyclin (PGI2) in our inflammatory model. As shown in
Figure 9, we found that ACE50 has a strong effect n the level of PGI2 (according to data not shown,
t e level of TxA2 was not influenced by ACE50).
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mean ± SEM of four individual experiments. ACE50, 50 µg/mL anthocyanin extract.
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Therefore, we investigated the expression of enzymes involved in prostacyclin synthesis by
measuring their mRNA levels. The mRNA of cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2),
and prostacyclin synthase (PGI2 synthase) was tested. It is well known that COX enzymes, with
particular reference to COX-2, and PGI2 synthase are upregulated in inflammation [31]. In our
experiments, we confirmed these facts. Furthermore, we found that ACE50 decreased the LPS-induced
expression of COX-1, COX-2, and PGI2 synthase as determined by Q-PCR (Figure 10). The greatest
mitigating effect was observed in the expression of PGI2 synthase (Figure 10A).
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Figure 10. (A) The level of prostacyclin (PGI2) synthase mRNA increased significantly compared to the
control after LPS-treatment indicated by *. # indicate the significant changes in PGI2 synthase mRNA
in LPS-induced inflammation and ACE50 treatment compared to the level of PGI2 synthase mRNA
in LPS-induced inflammation without ACE50. (B) Th level of cyclo xygenase-1 (COX-1) mRNA
increased significantly compared to the c ntrol after LPS-treatment indicated by *. # indicates the
significant changes in COX-1 mRNA in LPS-induced inflammation and ACE50 treatment compared
to the level of COX-1 mRNA in LPS-induced inflammation without ACE50. (C) The level of COX-2
RNA increased significantly compared to the control after LPS-treatment indicated by *. # indicates
the significant changes in COX-2 mRNA in LPS-induced inflammation and ACE50 treatment compared
to the level of COX-2 mRNA in LPS-induced inflammation without ACE50. Results are expressed
in the percentage of the control (100% is represented by the solid lines). Data are expressed as the
mean ± SEM of four individual experiments. ACE50, 50 µg/mL anthocyanin extract.
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3. Discussion
Endothelium plays an important role in mediating inflammation, maintaining hemostasis,
balancing vasodilatation and vasoconstriction, among other roles [33]. We investigated the effect of
anthocyanin-rich sour cherry extract on LPS-induced inflammation in HUVECs in relation to the
above. First, we assessed the optimal concentration of anthocyanin-rich sour cherry extract in our
experiments. MTT, apoptosis, and necrosis assays were performed to seek the maximal non-harmful
concentration. A reactive oxygen radical elimination ability test was carried out to seek the minimal
effective antioxidant concentration. Based on these measurements, the amount of 50 µg/mL ACE
(ACE50) was selected as the final concentration for further experiments.
Several studies have shown that anthocyanins are excellent antioxidant compounds [34].
Antioxidant properties may be mediated in several ways. On the one hand, anthocyanins as proton
donors can directly eliminate reactive species. Therefore, we tested the effect of ACE50 on the formation
of ROS in LPS-induced HUVECs. ACE50 was able to significantly reduce the formation of ROS. On the
other hand, flavonoids can indirectly increase the expression of gene-encoding γ-glutamyl cysteine
synthase, which determines the rate of glutathione synthesis [35,36]. We investigated the level of GSH
and confirmed that ACE50 increases the level of GSH. These observations demonstrate that ACE50 can
improve the imbalance of pro- and anti-oxidative agents, thereby alleviating oxidative stress.
Moreover, we examined the inflammatory response to LPS by measuring the secretion of
chemokines and cytokines. IL-6 is a soluble mediator with a pleiotropic effect on inflammation,
immune response, and hematopoiesis. It may have a central role in host defense mechanisms
because of its effect on B-lymphocyte, T-lymphocyte, and hematopoietic stem cells, among others [37].
Tumor necrosis factor alpha (TNF-α) is an inflammatory cytokine produced by macrophages and
monocytes during acute inflammation and is responsible for a diverse range of signaling events within
cells [38]. Endothelial cells also produce chemokines that regulate eosinophil chemotaxis including
RANTES [39]. Another chemokine, granulocyte-macrophage colony-stimulating factor (GM-CSF), is an
important hematopoietic growth factor and immune modulator. GM-CSF also has profound effects on
the functional activities of various circulating leukocytes [40]. Levels of IL-6, TNF-α, RANTES and
GM-CSF were investigated in our experimental setup to evaluate the effect of ACE50 on inflammation.
According to recently published articles, dietary anthocyanins can lower levels of these cytokines
and chemokines in vitro and in vivo [17,41,42]. In accordance with the above, sour cherry-originated
ACE50 decreased these pro-inflammatory cytokines and chemokines significantly. This suggests that
ACE50 can modulate inflammatory response.
Considering the multifunctionality of the endothelium and the above-mentioned observations,
we investigated the tPA, which serves as a cytokine and a hemostatic agent [30]. As a two-edged
sword, tPA can be a promising target to alleviate inflammatory changes. We confirmed that sour cherry
ACE50 decreases the level of tPA in LPS-induced HUVECs.
Furthermore, we investigated the effect of ACE50 on eicosanoids because arachidonic acid
derivatives play a pivotal role in the local regulation of inflammation [43]. We found that ACE50 has
a significant effect on PGI2 among eicosanoids but not on TxA2. To describe more accurately the
mechanism of action, we tested the expression of COX-1, COX-2, and PGI2 synthase. The data suggest
that the place of effect for the sour cherry ACE50 can found around the prostacyclin synthesis.
Since prostacyclin is a potent vasodilator, ACE50 may have a vasoactive effect. Further measurements
are needed to confirm that hypothesis.
In summary, ACE50 has a pleiotropic effect in our inflammation model, including anti-oxidative,
anti-inflammatory, hemostatic and vasoactive effects. With respect to mechanisms of action and
possible clinical value, further investigations are needed since the sour cherry anthocyanin extract may
have a therapeutic potential in endothelial dysfunction-associated diseases.
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4. Materials and Methods
4.1. Materials
Purified sour cherry anthocyanin extract (ACE) was prepared by solid phase extraction
procedure, as described earlier [22]. All other reagents were obtained from iBioTech Hungary
Ltd. (Budapest, Hungary) and Nucleotest Bio Ltd. (Budapest, Hungary).
4.2. Methods
4.2.1. Cell Culture Conditions
The human umbilical cord vein endothelial cells (HUVECs) were isolated from human umbilical
cords. Umbilical cords were obtained from the Department of Obstetrics and Gynaecology,
Clinical Centre, University of Debrecen, Debrecen, Hungary. The vein of the umbilical cord was
cannulated and washed twice with Hank’s Balanced Salt Solution (HBSS). Digestion of HUVECs was
performed with 22 U/100 mL collagenase solution incubating for 15 min at 37 ◦C. The cell pellet was
suspended and transferred to a 75 cm2 flask. HUVECs were grown using M199 medium supplemented
with 10% heat-inactivated FBS, 1% penicillin/streptomycin, 1% amphotericin B, 2 mM glutamine,
and Endothelial Cell Growth Medium-2 (EGM-2) at 37 ◦C in a humidified incubator under 5% CO2.
Media was changed every 48 h until cells reached 80% to 90% confluency. At confluency, cells were
either subcultured or used for experiments. For all experiments, cells were growing at passage
1–4. Media as described above was used as control. To create an inflammatory model, LPS was
added to M199 medium to a final concentration of 100 ng/mL. Cells were divided into three groups,
24 h incubating with M199 medium (Control), 24 h incubating with 100 ng/mL LPS (Control + LPS),
and 24 h incubating with 100 ng/mL LPS plus 50 µg/mL ACE (Control + LPS + ACE50).
4.2.2. Flow Cytometry Studies
For the identification of HUVECs, cells were incubated with four fluorescent dye-labeled antibodies
for 30 min at room temperature in the dark. Approximately 100,000 cells were used for one measurement.
Cell counting was performed using a Bürker chamber (Hirschmann Laboratory, Eberstadt, Germany).
Amounts of 20 µL of fluorescein-isothiocyante (FITC)-labeled mouse anti-human CD31, 20 µL
phycoerythrin (PE)-labeled anti-human CD54, 20µL allophycocyanin (APC)-labeled mouse anti-human
CD106, and 5 µL PerCP-Cy5.5 mouse anti-human CD45 were used for labelling. The measurements
were carried out using a Becton Dickinson FACSAriaIII Cell Sorter (Becton Dickinson, Mountain View,
CA, USA). FITC and PerCP-Cy5.5 were excited with a 488 nm laser (Becton Dickinson), and the emitted
green light of FITC was detected using a 530/30 band-pass filter (Becton Dickinson), whereas the
far-red fluorescence of PerCP-Cy5.5 was measured using a 635 dichroic mirror (Becton Dickinson) and
695/40 band-pass filter (Becton Dickinson). PE was excited by the 562 nm line of a solid state laser and
the emitted light was detected applying a 595/50 nm band-pass filter. APC was excited with a 635 nm
red laser and fluorescence intensity was detected using a 660/20 band-pass filter (Becton Dickinson).
In all, 20,000 cells/sample were recorded and analyzed. Cytofluorimetric data were analyzed using
FCS Express 4 Research Edition (De Novo Software, version 7, Glendale, CA, USA).
4.2.3. Determination of Cellular Viability
Cell viability was determined by MTT assay measuring the conversion of tetrazolium salt to
formazan crystals by mitochondrial dehydrogenases. Cells were seeded to 96-well plates at a density
of 20,000 cells per well in quadruplicates and were treated with sour cherry extract of different
concentrations (1, 5, 10, 50, and 100 µg/mL) for 24 and 48 h. Cells were then incubated with
0.5 mg/mL MTT solution for 3 h. Formazan crystals formed proportional to the number of viable
cells. After dissolving them in isopropyl alcohol, absorbance was measured colorimetrically at 465 nm
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using a Clariostar microplate reader (BMG Labtech, Ortenberg, Germany). The results were expressed
relative to 100% of the control group.
4.2.4. Determination of Apoptosis
Decrease in the mitochondrial membrane potential is one of the earliest markers of apoptosis.
Therefore, to estimate the process, the mitochondrial membrane potential of the HUVECs was
determined using DilC1(5) dye. Cells (20,000 cells/well) were cultured in 96-well plates and treated as
indicated in Section 4.2.4. After removal of the supernatants, the cells were incubated for 30 min with a
DilC1(5) working solution (50 µL/well) and then washed with PBS, and the fluorescence of DilC1(5)
was measured at 630 nm excitation and 670 nm emission wavelengths using a Clariostar microplate
reader. The results were expressed relative to 100% of the control group.
4.2.5. Determination of Necrosis
Necrotic processes were evaluated by SYTOX Green staining. Cells were cultured in 96-well
plates, and treated as indicated in Section 4.2.4. Then, the supernatants were discarded, and the cells
were incubated for 30 min with 1 µM SYTOX Green dye. After incubation, cells were washed with
PBS, and the fluorescence of SYTOX Green was measured at 490 nm excitation and 520 nm emission
wavelengths using a Clariostar microplate reader. The results were expressed relative to 100% of the
control group.
4.2.6. Measurement of ROS
The cells were treated in a 24-well plate and exposed to 100 µM 2′,7′-dichlorofluorescin diacetate
(DCFDA) for 1 h at 37 ◦C to label intracellular ROS. After incubation, the cells were washed twice with
PBS. Then, the labelled cells were monitoring every 6 h. Fluorescence intensity (excitation = 485 nm;
emission = 530 nm) was measured using a microplate reader (Clariostar; BMG Labtech). The results
were expressed relative to 100% of the control group.
4.2.7. Measurement of GSH Level
The assay was performed according to the manufacturer′s instructions (Abcam Plc., Cambridge,
UK) using a Glutathione Assay Kit (Abcam Plc.). The results were expressed relative to 100% of the
control group.
4.2.8. Luminex MagPlex Assay
HUVECs were treated with 100 ng/mL LPS for 24 h and the supernatant was collected and
centrifuged for 10 min 10,000 r·min−1 and stored at −80 ◦C. The supernatant levels of IL-6, GM-CSF,
TNF-α, and RANTES were determined using a MILLIPLEX MAP Human cytokine/chemokine
Magnetic Bead Panel (HCYTOMAG-60K-09, EMD Millipore Corp., Billerica, MA, USA) according to
the manufacturer′s instructions. The results were expressed relative to 100% of the control group.
4.2.9. ELISA
HUVECs were treated with 100 ng/mL LPS for 24 h and the supernatants were collected and
centrifuged for 10 min 10,000 r·min−1 and stored at −80 ◦C. The concentrations of PGI2 and tPA were
measured in the cell supernatant with a competitive (PGI2) and sandwich (tPA) ELISA (Abcam Plc.,
Cambridge, UK) according to the manufacturer’s instructions. The results were expressed relative to
100% of the control group.
4.2.10. Q-PCR
Q-PCR was performed on a Roche LightCycler 480 System (Roche, Basel, Switzerland)
using the 5′ nuclease assay. Total RNA was isolated using Extrazole. 1 µg of total RNA was
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reverse-transcribed into cDNA using an UltraScript 2.0 cDNA Synthesis Kit (PCR Biosystems,
London, UK). The amplification was performed using the 2× qPCRBIO Probe Mix No-ROX assay
(PCR Biosystems, London, UK). As internal control, glyceraldehyde 3-phosphate dehydrogenase was
determined. The results were expressed relative to 100% of the control group.
4.2.11. Statistical Analysis
For multiple comparisons, results were analyzed by ANOVA followed by modified t-test for
repeated measures according to Bonferroni’s method. Data were presented as mean ± SEM. p < 0.05
was considered statistically significant.
4.3. Ethics
The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved
by the Ethics Committee of the University of Debrecen (registration number RKEB/IKEB 3712-2012).
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